Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
General Dynamics approaches its October 28 earnings report with analyst targets still moving lower, Longview's activist stake continuing to shrink, and options traders rotating toward calls rather than puts.
The analyst picture has grown more cautious since the previous note. Bernstein's Douglas Harned cut his target to $365 from $407 on October 14, maintaining a Market Perform rating. That follows TD Cowen lowering to $380 from $420 on October 9, and Citigroup's move to $374 from $404 the week before. The direction of travel is consistent: targets are coming down across the board, with the Street mean now at $409, roughly 23% above the current price of $332.42. That gap is substantial, but it has been narrowing with each successive cut. Wells Fargo remains the most constructive at $440 with an Overweight rating, while the neutral-rated firms cluster in the $365 to $408 range. The bear case centers on execution risk: converting the aerospace and marine backlogs into booked revenue has been slower than the Street expected, and that drag is showing up in target compression even before the Q3 print. Bulls point to the FY26 defense budget environment and improving margins in the G700 program as the offset, but the market is evidently waiting for evidence.
The activist dimension has updated since last week's note. Longview Asset Management filed a 13D amendment on October 6, reducing its declared stake from 10% to 9%, roughly 24.4 million shares, and still the largest single reported position on the register. The direction remains downward, not upward. As with all Schedule 13D/G disclosures, this stake is as-last-disclosed around the 5% threshold; a holder who drops below that level may not file again. Meanwhile, the index-passive giants have been moving the other way. BlackRock added around 709,000 shares in the most recent reported period, and JP Morgan Asset Management added roughly 344,000. The net picture is one of passive accumulation offsetting active reduction, which is a less alarming read than the Longview headline alone implies.
Short positioning is not a meaningful part of the story here. Short interest has fallen 19% in a week and 28% over the past month, now at just 0.74% of the free float. With borrow availability at effectively uncapped levels and cost to borrow barely above 0.34%, there is no pressure in the lending market. The ORTEX short score has drifted down to 28.5, consistent with low and declining short conviction. Options positioning has tilted mildly toward calls this week. The put/call ratio of 0.64 is about one standard deviation below its 20-day average of 0.68, near the lower end of its 52-week range of 0.51 to 0.80. That is a modest signal that options flow has become more constructive, even as analyst targets have moved in the opposite direction.
The stock is down 6.6% over the past month but essentially flat on the week at $332.42. Close peers have had a rougher week: LMT fell 1.2%, RTX slipped 0.15%, and TXT dropped 1.4%. GD's slight outperformance on the week suggests the sector-wide pressure is not uniquely concentrated here. The prior earnings event in July produced a 2.8% decline the next day, and a further 2.3% drop over the following five sessions, a pattern worth keeping in mind as Q3 approaches.
With two weeks to the October 28 report, the question is whether the backlog conversion problems that have driven target cuts this month show up in Q3 numbers or whether the defense budget tailwinds and aerospace margin progress are enough to stabilize the narrative.
See the live data behind this article on ORTEX.
Open GD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
